Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of Ursofalk 500 mg tablets versus
Ursofalk 500 mg capsules in the treatment of Primary Biliary Cirrhosis (PBC).